BeyondSpring Inc Earnings

The next earnings date for BeyondSpring Inc is November 11, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of BeyondSpring Inc Earnings

No results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

BeyondSpring Inc Earnings: Historical

08/14/2026---$-0.02---
05/06/2026---$-0.05---
11/12/2025---$-0.05---
08/13/2025---$-0.04---
04/30/2025---$-0.06-105.88%
11/27/2024---$0-100.00%
08/29/2024---$-0.19-123.75%
05/01/2024---$0100.00%
12/21/2023---$0100.00%
07/10/2023---$0100.00%

More About BeyondSpring Inc

Country
USA
Full Time Employees
44

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform. The company's lead asset is Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia (CIN). It also develops Plinabulin in combination with Plinabulin+docetaxel vs. docetaxel alone for the treatment of NSCLC and epidermal growth factor receptor wild type. In addition, the company develops Plinabulin in combination with various immuno-oncology agents and chemotherapy and radiation; nivolumab, a PD-1 antibody that has completed phase 1 clinical trials for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer (ES-SCLC); in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers; and pembrolizumab, etoposide, and platinum to treat extensive-stage small cell lung cancer. Further, it engages in the development of three small-molecule immune agents in preclinical stages; and a drug discovery platform to develop therapeutic agents from internal research and development efforts and from collaboration. The company was founded in 2010 and is headquartered in Florham Park, New Jersey.

“BeyondSpring Inc Earnings” Can Refer to the BeyondSpring Inc Earnings Date

Some people say “BeyondSpring Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my BeyondSpring Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning BeyondSpring Inc Stock on the Earnings Date

If you own BeyondSpring Inc stock (BYSI) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for BeyondSpring Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading BeyondSpring Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More BeyondSpring Inc Earnings

You can contact us any time if you would like to ask questions about BeyondSpring Inc earnings or anything else related to the stock market.